Ive been in and out since below a dollar over a year ago and am well versed in Biotech....I repeat long term there's no issue with PRED being higher but AT PRESENT they haven't justified a BILLION dollar market cap. they still are a genetic analysis company with ultimate goal of using Crisper or other technology against their data bases. Let's not get blind to facts.They are an R&D enterprise with respect to endometriosis and a collaborative deal with TMO details still to be announced .again Im long term bullish with no ulterior motives but to see the company succeed .
News 
Market Data 
Discover 
